Page last updated: 2024-11-03

resorcinol and Prostatic Neoplasms

resorcinol has been researched along with Prostatic Neoplasms in 2 studies

resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nepali, K1
Lin, MH1
Chao, MW1
Peng, SJ1
Hsu, KC1
Eight Lin, T1
Chen, MC1
Lai, MJ1
Pan, SL1
Liou, JP1
Nakamura, A1
Shirai, T1
Takahashi, S1
Ogawa, K1
Hirose, M1
Ito, N1

Other Studies

2 other studies available for resorcinol and Prostatic Neoplasms

ArticleYear
Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells.
    Bioorganic chemistry, 2019, Volume: 91

    Topics: Amides; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug;

2019
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
    Cancer letters, 1991, Jul-04, Volume: 58, Issue:3

    Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia;

1991